On February 27, 2024, Qualigen Therapeutics, Inc. closed the transaction.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.18 USD | -0.17% |
|
+1.64% | -67.27% |
1st Jan change | Capi. | |
---|---|---|
-67.27% | 11.37L | |
+31.84% | 5.27TCr | |
+37.91% | 3.9TCr | |
-9.35% | 3.85TCr | |
+25.93% | 3.04TCr | |
-11.17% | 2.64TCr | |
+10.58% | 2.61TCr | |
+45.10% | 1.42TCr | |
+32.90% | 1.26TCr | |
-5.40% | 1.15TCr |
- Stock Market
- Equities
- QLGN Stock
- News Qualigen Therapeutics, Inc.
- Qualigen Therapeutics, Inc. announced that it has received $0.55 million in funding from Alpha Capital Anstalt